Andreas Weiss

Andreas Weiss has a diverse and extensive work experience in the field of biotechnology and pharmaceuticals. Andreas began their career as a PHD student and Postdoc at Novartis Institutes for BioMedical Research (NIBR) in 2005, where they focused on research and development. In 2009, they worked as a Consultant at Strategic Access Solutions Ltd - Stratas Partners.

Weiss then joined Novartis in 2010 as the Head of Laboratory, where they managed and directed laboratory operations. In 2013, they became the Scientific Director of Drug Discovery and Technology at IRBM-Promidis, where they oversaw the scientific aspects of drug discovery projects.

From 2014 to 2019, Weiss served as the Vice President of Neurobiology at Evotec, leading research and development efforts in the field of neurobiology. Andreas then transitioned to the role of Vice President of Early Drug Discovery at Evotec in 2019, where they focused on developing new drug candidates.

Currently, Weiss holds the position of Senior Vice President of Protein Homeostasis Biology at Evotec starting from September 2021, where they are responsible for leading protein homeostasis research and development initiatives.

Throughout their career, Weiss has held various leadership positions and has demonstrated expertise in different areas of the biotechnology and pharmaceutical industry.

Andreas Weiss has attended Bielefeld University, the Max Planck Institute for Experimental Endocrinology, and the University of Notre Dame. No degree or field of study information is provided for these institutions.